BioSpace News Archive

The company has decided to split its business into two units - consumer healthcare and home and hygiene products

APAC Surgical Staplers Device Market is expected to reach $682.4M by 2024 from $336.8M in 2016, at a CAGR of 9.2% in the forecast period 2017 to 2024.

The long term study results were published online in Blood.

Huawei and Philips announced a China cloud healthcare partnership that uses AI to deliver best diagnostic practices and monitoring in second tier China cities. The partnership combines Huawei’s IT capability with Phillips’ knowledge of diagnostic scanning devices.

Vertex has done everything an investor could ask for in 2017, including double its market cap to almost $40B.

Mark Lanier, a lead attorney for the plaintiffs in one of six cases being tried raised the tampering issue during an Oct. 16 hearing.

Biogen confirms its comprehensive approach to tackle multiple sclerosis (MS) at the seventh Joint Meeting of the European Committee for Treatment and Research in MS and Americas Committee for Treatment and Research in MS (ECTRIMS-ACTRIMS; 25 - 28 October).

Trovagene today announced positive data from preclinical research demonstrating synergy of PCM-075, its oral, highly-selective Polo-like Kinase 1 (PLK1) Inhibitor, in combination with abiraterone (Zytiga - J&J)/

Haemonetics announced the election of Robert E. Abernathy to its Board of Directors.

On August 2, 2017, an American surgical team conducted a surgery to replace the sternum and partial ribcage of a 20 year-old woman using a custom 3D-printed composite titanium/porous polyethylene implant. It is the first time this technology has been used in the United States and only the second time in the world that a 3D-printed composite sternum and ribcage has been implanted.